|
|
||||||||
CSIRO Division of Animal Health, Animal Health Research Laboratory, Private Bag No. 1, P.O., Parkville, Victoria 3052, Australia
VP-2b, a major structural protein of infectious bursal disease virus (IBDV), and its precursor protein VP-2a were separated in a soluble form from the supernatant of ultracentrifuged viruses by using a monoclonal antibody specific for VP-3, the other major structural protein, to remove soluble VP-3 and remaining virus particles. The native VP-2a/2b inhibited the majority of virus-neutralizing (VN) activity in chicken anti-IBDV sera and chickens immunized with VP-2a/2b produced VN antibodies that passively protected susceptible chickens from infection. However, the separated VP2a/2b was not as immunogenic as intact virus particles. VP-2a/2b would appear to contain a conformational epitope which is destroyed by SDS and boiling and which may prove to be of critical importance in a subunit vaccine against type 1 IBDV.
Keywords: IBDV, immunogen, vaccine development
Received 25 July 1988;
accepted 8 February 1989.
This article has been cited by other articles:
![]() |
T. Letzel, F. Coulibaly, F. A. Rey, B. Delmas, E. Jagt, A. A. M. W. van Loon, and E. Mundt Molecular and Structural Bases for the Antigenicity of VP2 of Infectious Bursal Disease Virus J. Virol., December 1, 2007; 81(23): 12827 - 12835. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Villanueva, J. L. Galaz, J. A. Valdes, M. M. Jashes, and A. M. Sandino Genome Assembly and Particle Maturation of the Birnavirus Infectious Pancreatic Necrosis Virus J. Virol., December 15, 2004; 78(24): 13829 - 13838. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Huang, S. Elankumaran, A. S. Yunus, and S. K. Samal A Recombinant Newcastle Disease Virus (NDV) Expressing VP2 Protein of Infectious Bursal Disease Virus (IBDV) Protects against NDV and IBDV J. Virol., September 15, 2004; 78(18): 10054 - 10063. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Dieye, A. J. W. Hoekman, F. Clier, V. Juillard, H. J. Boot, and J.-C. Piard Ability of Lactococcus lactis To Export Viral Capsid Antigens: a Crucial Step for Development of Live Vaccines Appl. Envir. Microbiol., December 1, 2003; 69(12): 7281 - 7288. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tsukamoto, S. Saito, S. Saeki, T. Sato, N. Tanimura, T. Isobe, M. Mase, T. Imada, N. Yuasa, and S. Yamaguchi Complete, Long-Lasting Protection against Lethal Infectious Bursal Disease Virus Challenge by a Single Vaccination with an Avian Herpesvirus Vector Expressing VP2 Antigens J. Virol., May 3, 2002; 76(11): 5637 - 5645. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Brandt, K. Yao, M. Liu, R. A. Heckert, and V. N. Vakharia Molecular Determinants of Virulence, Cell Tropism, and Pathogenic Phenotype of Infectious Bursal Disease Virus J. Virol., December 15, 2001; 75(24): 11974 - 11982. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Caston, J. L. Martinez-Torrecuadrada, A. Maraver, E. Lombardo, J. F. Rodriguez, J. I. Casal, and J. L. Carrascosa C Terminus of Infectious Bursal Disease Virus Major Capsid Protein VP2 Is Involved in Definition of the T Number for Capsid Assembly J. Virol., November 15, 2001; 75(22): 10815 - 10828. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Martinez-Torrecuadrada, B. Lazaro, J. F. Rodriguez, and J. I. Casal Antigenic Properties and Diagnostic Potential of Baculovirus-Expressed Infectious Bursal Disease Virus Proteins VPX and VP3 Clin. Vaccine Immunol., July 1, 2000; 7(4): 645 - 651. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |